Atomwise Company
Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.
Investors
.png)
%20.jpg)
.png)
.png)
Connections from
Founded Date:
2012-01-01
Last Funding Type:
Grant
Headquarters:
United
Investors Number:
22.0
Technology:
['BioTech & HealthTech']
Employee Number:
94
Industry:
Application Software
Estimated Revenue:
2.3
Last Funding Date:
2020-10-06
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Total Funding:
176645000.0